comparemela.com

Page 2 - Temi Folaranmi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Approves Additional Option for Measles, Mumps and Rubella Vaccination

The FDA has approved the Priorix vaccine for the prevention of measles, mumps and rubella in individuals 12 months of age and older.

Centers for diseaseDrug administrationPrevention advisory committee on immunization practicesUs medical affairsTemi folaranmiVice presidentVaccines therapeutic area headDisease controlAdvisory committeeImmunization practices

GlaxoSmithKline (GSK) announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older

GlaxoSmithKline (GSK) announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New zealandJudy stewartUs centers for diseaseDrug administrationAdvisory committee on immunization practicesUs medical affairsRubella vaccineSenior vice presidentDisease controlFor childrenTemi folaranmiVice presidentVaccines therapeutic area headImmunization practices

GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesNew zealandUnited kingdom generalUnited kingdomCity ofJudy stewartSimon mooreKathleen quinnJosh williamsJeff mclaughlinSonya ghobrialSean clementsMick readeyTim foleyJames dodwellNick stone

GSK announces US FDA approval of Priorix for the prevention of measles, mumps and rubella in individuals 12 months of age and older

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Priorix ( Measles, Mumps and Rubella Vaccine, Live ) for active immunisation for the prevention of measles, mumps and rubella (MMR) in individuals 12 months of age and older.

New zealandUnited kingdomJudy stewartUs centers for diseaseDrug administrationAdvisory committee on immunization practicesUs medical affairsLondon united kingdomRubella vaccineSenior vice presidentDisease controlFor childrenTemi folaranmiVice presidentVaccines therapeutic area headImmunization practices

GSK PLC s Priorix MMR vaccine gets US FDA approval

GSK PLC said its Priorix vaccine has been approved by the US Food and Drug Administration (FDA) for active immunisation for the prevention of measles, mumps.

New zealandJudy stewartUs centers for diseaseDrug administrationUs medical affairsDisease controlFor childrenTemi folaranmi

vimarsana © 2020. All Rights Reserved.